Long‐term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium‐enhanced MRI scans: case report and implications
- 1 July 2007
- journal article
- case report
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2 (4) , 199-205
- https://doi.org/10.1002/cmmi.146
Abstract
Nephrogenic systemic fibrosis (NSF) is a painful and debilitating fibrosing disorder of the skin and systemic tissues. It is associated with exposure to Gd, used in MRIs and MRAs, in patients with renal insufficiency. We here present an illustrative example of a young patient who underwent multiple Gd‐enhanced scans, both before and after developing severe NSF. We examined biopsy tissues for quantification of detectable insoluble Gd deposits using automated scanning electron microscopy/energy dispersive X‐ray spectroscopy. High concentrations of Gd associated with calcium and phosphorus in skin persisted even 3 years after the last exposure to Gd. Such long‐term retention of Gd raises further concerns about the utility and safety of Gd‐based contrast agents. Residual Gd chelates, after initial and rapid renal clearance, can dissociate into insoluble, toxic Gd3+ that precipitates with tissue anions. Bone serves as a site for Gd storage. Subsequent clearance and mobilization from such stores may explain the variable latency of onset of NSF. We hypothesize that long‐term persistence and slow release of Gd3+ from bone stores can be a cause for concern of Gd‐associated toxicity with long latency. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Automated Scanning Electron Microscopy and X-Ray Microanalysis for in situ Quantification of Gadolinium Deposits in SkinJournal of Electron Microscopy, 2007
- Nephrogenic Systemic FibrosisClinical Journal of the American Society of Nephrology, 2007
- Vascular calcification: Not so crystal clearKidney International, 2007
- Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a reviewFundamental & Clinical Pharmacology, 2006
- Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agentsContrast Media & Molecular Imaging, 2006
- Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass SpectroscopyInvestigative Radiology, 2006
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsPublished by Elsevier ,2000
- Exposure, metabolism, and toxicity of rare earths and related compounds.Environmental Health Perspectives, 1996
- Gd-DPTA: an i.v. contrast agent for clinical MRIInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988